Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Amcare Women’s & Children’s Hospital is a private women’s and children’s specialty hospital operating within Amcare Medical Group, a China-based premium healthcare network founded in 2006. The Beijing hospital and broader group focus on obstetrics, gynecology, pediatrics, assisted reproduction, postpartum care, and a growing set of multidisciplinary specialty services including oncology, internal medicine, surgery, orthopedics, ENT, ophthalmology, dermatology, dentistry, and traditional Chinese medicine. The organization is positioned as a high-end clinical care provider rather than a therapeutic drug developer, with revenue derived from hospital, outpatient, fertility, and related healthcare services. Amcare also highlights JCI-style standards, medical AI initiatives, and exploratory work in gene and cell therapy through its clinical innovation platform. For a biotech analyst, this entity is best understood as a commercial private healthcare delivery platform with fertility and women’s/children’s care as its historical core.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Amcare Women’s & Children’s Hospital.